The Evolving Landscape of JAK Inhibitors: Revisiting Selectivity, Delivery & Safety

Time: 10:15 am
day: Day One

Details:

  • Pharma’s drive for exquisite biochemical selectivity for inflammatory diseases
  • Oral and topical JAK inhibitors in clinical development
  • The emerging safety landscape (hematology, infection, cardiovascular & oncology)

Speakers: